Dr. Puja Nistala
Claim this profileUniversity of Missouri - Ellis Fischel
About Puja Nistala
Education:
- Earned an MD (Doctor of Medicine).
- Holds an MBBS (Bachelor of Medicine, Bachelor of Surgery).
Experience:
- Serves as the Margaret Proctor Mulligan Assistant Professor of Clinical Medicine at the University of Missouri.
- Acts as the Medical Director of the Clinical Trials Office at Ellis Fischel Cancer Center.
- Oncology Breast Program Director at Ellis Fischel Cancer Center.
Area of expertise
Breast Cancer
Puja Nistala has run 8 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Puja Nistala has run 6 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Missouri - Ellis Fischel
University Of Missouri
Clinical Trials Puja Nistala is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting
1 award
N/A
More about Puja Nistala
Clinical Trial Related
4 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Puja Nistala has experience with
- Radiation Therapy
- Paclitaxel
- Atezolizumab
- Biospecimen Collection
- Gemcitabine Hydrochloride
- Oxaliplatin
Breakdown of trials Puja Nistala has run
Breast Cancer
Breast cancer
Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Puja Nistala specialize in?
Puja Nistala focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Puja Nistala currently recruiting for clinical trials?
Yes, Puja Nistala is currently recruiting for 9 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Puja Nistala has studied deeply?
Yes, Puja Nistala has studied treatments such as Radiation Therapy, Paclitaxel, Atezolizumab.
What is the best way to schedule an appointment with Puja Nistala?
Apply for one of the trials that Puja Nistala is conducting.
What is the office address of Puja Nistala?
The office of Puja Nistala is located at: University of Missouri - Ellis Fischel, Columbia, Missouri 65212 United States. This is the address for their practice at the University of Missouri - Ellis Fischel.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.